You are viewing a javascript disabled version of the site. Please enable Javascript for this site to function properly.
Go to headerGo to navigationGo to searchGo to contentsGo to footer
In content section. Select this link to jump to navigation

Human Antibodies - Volume 11, issue 1-2

Purchase individual online access for 1 year to this journal.

Price: EUR 145.00
ISSN 1093-2607 (P)
ISSN 1875-869X (E)

Human Antibodies is an international journal designed to bring together all aspects of human hybridomas and antibody technology, along with factors that modulate host antibody repertoire and effectiveness, such as vaccines, infectious agents, and microbiome. This includes fundamental research, applied science and clinical applications.

Emphasis in the published articles is on antisera, monoclonal antibodies, fusion partners, EBV transformation, transfections, in vitro immunization, defined antigens, tissue reactivity, scale-up production, chimeric antibodies, autoimmunity, natural antibodies/immune response, anti-idiotypes, and hybridomas secreting interesting growth factors. Immunoregulatory molecules, including T cell hybridomas, will also be featured.

results per page

Keynotes

Article Type: Abstract

DOI: 10.3233/HAB-2002-111-201

Citation: Human Antibodies, vol. 11, no. 1-2, pp. 1-2, 2002

Get PDF

Session 1: Cancer

Article Type: Abstract

DOI: 10.3233/HAB-2002-111-202

Citation: Human Antibodies, vol. 11, no. 1-2, pp. 3-7, 2002

Get PDF

Session 2: Autoimmunity

Article Type: Abstract

DOI: 10.3233/HAB-2002-111-203

Citation: Human Antibodies, vol. 11, no. 1-2, pp. 9-12, 2002

Get PDF

Session 3: Emerging technologies

Article Type: Abstract

DOI: 10.3233/HAB-2002-111-204

Citation: Human Antibodies, vol. 11, no. 1-2, pp. 13-15, 2002

Get PDF

Session 4: Molecular biology (I)

Article Type: Abstract

DOI: 10.3233/HAB-2002-111-205

Citation: Human Antibodies, vol. 11, no. 1-2, pp. 17-18, 2002

Get PDF

Session 5: Molecular biology (II)

Article Type: Abstract

DOI: 10.3233/HAB-2002-111-206

Citation: Human Antibodies, vol. 11, no. 1-2, pp. 19-20, 2002

Get PDF

Session 7: Molecular biology (III)

Article Type: Abstract

DOI: 10.3233/HAB-2002-111-207

Citation: Human Antibodies, vol. 11, no. 1-2, pp. 21-23, 2002

Get PDF

Session 8: Infectious diseases

Article Type: Abstract

DOI: 10.3233/HAB-2002-111-208

Citation: Human Antibodies, vol. 11, no. 1-2, pp. 25-28, 2002

Get PDF

Poster session

Article Type: Abstract

DOI: 10.3233/HAB-2002-111-209

Citation: Human Antibodies, vol. 11, no. 1-2, pp. 29-48, 2002

Get PDF

Conference program

Article Type: Other

DOI: 10.3233/HAB-2002-111-210

Citation: Human Antibodies, vol. 11, no. 1-2, pp. 49-54, 2002

Get PDF

Prevalence of tetanus immunity in the Egyptian population

Authors: Redwan, EL-Rashdy M. | AL-Awady, Mostafa K.

Article Type: Research Article

Abstract: Our aim was to determine the level of tetanus immunity in the general Egyptian population. The surveyed population consisted of 709 healthy subjects from five regions of Egypt, 2 month to 105 years of age. We used an ELISA assay to determine titers of anti-tetanus IgG. According to the widely used criteria, 31.7% was susceptible to tetanus (IgG level < 0.15 IU/ml), 15.7% protection (0.15–1.0 IU/ml), and 52.6% ≥ 1.0 IU/ml). The results revealed that the majority (68.3%) population from 2 months to 50 years had a protective level of IgG against tetanus. The level of susceptibility increases with age … Show more

DOI: 10.3233/HAB-2002-111-211

Citation: Human Antibodies, vol. 11, no. 1-2, pp. 55-59, 2002

Price: EUR 27.50
Show more